We are proud to announce the official launch of Qritive Academy, a dedicated online platform designed to support continuous learning and professional development in the field of pathology. Developed with the mission to make high-quality education more accessible to pathologists worldwide, the platform offers both foundational and advanced content tailored to today’s diagnostic needs.

Qritive is proud to announce that its AI-powered diagnostic solution, QAi Prostate Grade, has received Class C In Vitro Diagnostic (IVD) registration from Singapore’s Health Sciences Authority (HSA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics. 

Qritive is pleased to announce that its AI-powered solution, QAi Prostate Grade, has received official market approval from the Department of Health – Abu Dhabi following a comprehensive Health Technology Assessment (HTA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics. 

Singapore, June 30, 2025  — Qritive participated in the European Congress on Digital Pathology (ECDP) 2025, held in Barcelona, Spain,...

Qritive at USCAP 2025: Presenting AI-Powered Study on Lymph Node Metastasis Detection

Watch the video to learn how our AI modules are transforming modern pathology workflows. Singapore, January 17, 2024  — Qritive offers a...